Work

TABLE 1 from Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells

Year: 2024

Type: other

Abstract: Six chordoma cell lines; established from 3 from clival tumor patients (UM-Chor1, MUG-CC1, UM-Chor5), and 3 sacral tumor patients (JHC7, U-CH1, U-CH2) were analyzed by flow cytometry to quantify expression surface markers MHC-I/HLA-A,B,C, PD-L1, and EGFR. Cell surface expression of each marker is reported in % positive cells and MFI.

DOI: 10.1158/2767-9764.27332386

Authors: Austin T.K. Hoke, Michelle R. Padget, Kellsye P. Fabian, Anjali Nandal, Gary L. Gallia, Marijo Bilusic, Patrick Soon-Shiong, James W. Hodge, Nyall R. London

Language: English

Topic: Bone Tumor Diagnosis and Treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4403895388

Cites:

Cited by:

Related to: 10